2026 DayOne Accelerator Applications Open for Healthtech Startups

Jan de Vries · 2026-05-13

If you're building a healthtech or techbio startup and dreaming of working with big pharma, this might be exactly what you've been waiting for. The DayOne Accelerator, based in Basel, Switzerland, just opened its 2026 applications. And here's the best part: it's free and they won't take any equity. DayOne launched back in 2018 and has already helped over 128 ventures get off the ground. They focus on startups that can speed up pharma R&D, which is a massive pain point for drug companies. Think about it: getting a new drug to market takes over a decade and costs billions. Any tool that can shave time off that process is gold. ### What's the Deal? The program runs for three months in a hybrid format, meaning you get both online sessions and in-person time in Basel. They connect you with top life science companies, research labs, mentors, and investors who actually know the industry. No fluff, just real connections. DayOne is looking for solutions in areas like: - Drug discovery and clinical development - Biomarkers and companion diagnostics - Data tools that improve R&D workflows - Organ-on-chip systems and organoids - Lab automation and non-animal testing methods - AI for patient engagement, remote monitoring, and real-world evidence They're not interested in startups that just build their own drug pipeline. Instead, they want technology platforms that can help pharma companies do their job better. That's a smart focus.  ### Who Should Apply? If you're an early-stage healthtech or techbio startup, from pre-incorporation all the way to Series A, and you've raised less than $10 million in dilutive funding, you're in their sweet spot. DayOne wants ventures that have a high-potential product and are genuinely interested in partnering with pharmaceutical companies. Selected startups get one-on-one mentorship to sharpen their pharma-specific pitch. You'll also get access to Basel's powerhouse life sciences network. And since the program is equity-free and fee-free, you keep full ownership of your company. For the most promising teams, there's even a follow-up program called DayOne NEXT. That's where things get really interesting. ### Key Dates and Details Mark your calendar. Applications are open from March 31 to May 31, 2026. Here's the full timeline: - **March 31 - May 31, 2026**: Call for applications open - **June 25 - 26, 2026**: Selection days (15 startups get chosen) - **September 7 - 8, 2026**: Kickoff bootcamp in Basel with workshops and networking - **Early December 2026**: Innovation showcase in Basel DayOne NEXT offers up to $63,000 in cash grants (converted from CHF 50K), another $63,000 in tailored services, and 12 months of free office space at Switzerland Innovation Park Basel Area. They also help with relocation and give you long-term support from industry experts and investors. That's a serious package. ### Real Results Since 2018, DayOne has supported more than 128 ventures, including over 60 healthtech startups. Some of the names that went through the program include InSilicoTrials, Risklick, TrialHub, Oncoustics, Theremia, and Lemna Bio. These aren't just random startups; they're companies that are actually making waves in pharma R&D. If you're serious about breaking into the European life sciences scene, this accelerator could be your ticket. The best part? You can apply without giving up a single share of your company. That's rare in the startup world. So take a deep breath, check if your startup fits, and get your application ready. The deadline is May 31, 2026. Don't sleep on this one.